Alkem Labs Equity Shareholders Meeting on Aug 17 for Amalgamation Scheme

Alkem Laboratories Ltd. has announced a meeting of its equity shareholders to be held on August 17, 2026, at 11:00 a.m. IST via video conference. The primary agenda is to consider and approve a Scheme of Amalgamation. This meeting is convened pursuant to an order from the National Company Law Tribunal (NCLT), Mumbai Bench. The notice includes details on remote e-voting, e-voting during the meeting, and attending via VC/OAVM. The full notice, explanatory statement, and annexures, including the Scheme of Arrangement with Adroit Biomed Limited, financial statements for FY26, and auditor certificates, are available on the company's website. The cut-off date for e-voting eligibility is August 10, 2026.